EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
   3.5.3.18 | Bronchopulmonary Dysplasia |
26663142 |
A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 3.5.3.18 | Hypertension, Pulmonary |
26663142 |
A single nucleotide polymorphism in the dimethylarginine dimethylaminohydrolase gene is associated with lower risk of pulmonary hypertension in bronchopulmonary dysplasia. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 3.5.3.18 | Diabetes Mellitus |
25701782 |
Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: Role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
3
0 |
| 3.5.3.18 | Diabetes Mellitus, Type 2 |
25701782 |
Accelerated onset of senescence of endothelial progenitor cells in patients with type 2 diabetes mellitus: Role of dimethylarginine dimethylaminohydrolase 2 and asymmetric dimethylarginine. |
causal interaction
diagnostic usage
ongoing research
unassigned |
4
4
3
0 |
| 3.5.3.18 | Glioma |
21590769 |
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
1
2
3 |
| 3.5.3.18 | Neoplasms |
21590769 |
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
1
2
3 |
| 3.5.3.18 | nitric-oxide synthase (nadph) deficiency |
19666122 |
ADMA and the role of the genes: Lessons from genetically modified animals and human gene polymorphisms. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
1
1
0 |
| 3.5.3.18 | Diabetic Nephropathies |
31818438 |
ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus. |
diagnostic usage
ongoing research
unassigned |
1
1
0 |
| 3.5.3.18 | Diabetic Nephropathies |
29096857 |
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy. |
ongoing research
unassigned |
1
0 |
| 3.5.3.18 | Diabetic Nephropathies |
23147199 |
ADMA, SDMA and L-arginine/ADMA Ratio but not DDAH Genetic Polymorphisms are Reliable Predictors of Diabetic Nephropathy Progression as Identified by Competing Risk Analysis. |
diagnostic usage
unassigned |
3
0 |
